Avastin and the Power of Hope

This week, an FDA panel unanimously voted to revoke its approval of Avastin (bevacizumab) for breast cancer. The decision evoked cheers from some groups and jeers from others.  At least one group derided the decision as the work of a  “death panel.” Initially hailed as a wonder drug, Avastin is a monoclonal antibody first approved […]

Could we make conferences less sucky?

I’m not a big fan of conferences. I loathe spending vast stretches of time indoors, especially if it requires planting my butt in uncomfortable chairs and wearing clothes with buttons and shoes that aren’t flip flops. Yet I continue to attend meetings, because they offer opportunities to interact with smart people who are thinking about […]

Guest Post: Lies and the Lying Bicyclist Who Tells Them

Tyler Hamilton has finally confessed. I am not inclined to give him another hug. In 2007, I wrote a Bicycling magazine feature about Tyler, his supporters and why I don’t believe. (You can read the story here.) While writing the Bicycling story, I spent a lot of time with Tyler and his fans. Tyler— a […]